Resmed Inc Stock Performance
| RMD Stock | USD 252.86 2.76 1.10% |
The company holds a Beta of -0.3, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning ResMed are expected to decrease at a much lower rate. During the bear market, ResMed is likely to outperform the market. At this point, ResMed Inc has a negative expected return of -0.18%. Please make sure to check ResMed's treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day median price , to decide if ResMed Inc performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days ResMed Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's primary indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders. ...more
Actual Historical Performance (%)
One Day Return 0.93 | Five Day Return 1.52 | Year To Date Return 10.48 | Ten Year Return 340.08 | All Time Return 37.5 K |
Forward Dividend Yield 0.0095 | Payout Ratio | Last Split Factor 2:1 | Forward Dividend Rate 2.4 | Dividend Date 2025-12-18 |
1 | Disposition of 8009 shares by Michael Farrell of ResMed at 101.64 subject to Rule 16b-3 | 09/08/2025 |
| ResMed dividend paid on 18th of September 2025 | 09/18/2025 |
2 | 1 Healthcare Stock to Research Further and 2 We Ignore | 10/24/2025 |
3 | ResMed shares charge higher on strong Q1 update | 10/30/2025 |
4 | ASX 200 Outlook Australian Shares Advance as Trade Calm Boosts Sentiment | 10/31/2025 |
5 | Healthcare Giant Faces Market Pressure Amid ASX 200 Momentum | 11/03/2025 |
6 | How to grow an ASX share investment portfolio to 50,000 from zero | 11/04/2025 |
7 | ResMed Inc. RMD Shares Bought by Versor Investments LP | 11/05/2025 |
8 | ResMeds Q3 Earnings Call Our Top 5 Analyst Questions | 11/06/2025 |
9 | Scott Power ASX health sector dips, CSL steadies, Imricor delivers jolt of good news | 11/07/2025 |
10 | How to make your first 10,000 in the ASX share market | 11/10/2025 |
| Begin Period Cash Flow | 238.4 M | |
| Total Cashflows From Investing Activities | -200 M |
ResMed Relative Risk vs. Return Landscape
If you would invest 28,472 in ResMed Inc on August 14, 2025 and sell it today you would lose (3,186) from holding ResMed Inc or give up 11.19% of portfolio value over 90 days. ResMed Inc is generating negative expected returns assuming volatility of 1.1842% on return distribution over 90 days investment horizon. In other words, 10% of stocks are less volatile than ResMed, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
ResMed Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ResMed's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as ResMed Inc, and traders can use it to determine the average amount a ResMed's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1506
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | RMD |
Estimated Market Risk
| 1.18 actual daily | 10 90% of assets are more volatile |
Expected Return
| -0.18 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.15 actual daily | 0 Most of other assets perform better |
Based on monthly moving average ResMed is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ResMed by adding ResMed to a well-diversified portfolio.
ResMed Fundamentals Growth
ResMed Stock prices reflect investors' perceptions of the future prospects and financial health of ResMed, and ResMed fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ResMed Stock performance.
| Return On Equity | 0.25 | ||||
| Return On Asset | 0.14 | ||||
| Profit Margin | 0.27 % | ||||
| Operating Margin | 0.35 % | ||||
| Current Valuation | 35.97 B | ||||
| Shares Outstanding | 145.97 M | ||||
| Price To Earning | 73.48 X | ||||
| Price To Book | 5.96 X | ||||
| Price To Sales | 7.01 X | ||||
| Revenue | 5.15 B | ||||
| Gross Profit | 3.19 B | ||||
| EBITDA | 1.91 B | ||||
| Net Income | 1.4 B | ||||
| Cash And Equivalents | 1.21 B | ||||
| Cash Per Share | 1.87 X | ||||
| Total Debt | 882.32 M | ||||
| Debt To Equity | 0.27 % | ||||
| Current Ratio | 2.80 X | ||||
| Book Value Per Share | 41.94 X | ||||
| Cash Flow From Operations | 1.75 B | ||||
| Earnings Per Share | 9.77 X | ||||
| Market Capitalization | 36.85 B | ||||
| Total Asset | 8.17 B | ||||
| Retained Earnings | 6.08 B | ||||
| Working Capital | 2.49 B | ||||
| Current Asset | 1.42 B | ||||
| Current Liabilities | 637.99 M | ||||
About ResMed Performance
By analyzing ResMed's fundamental ratios, stakeholders can gain valuable insights into ResMed's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if ResMed has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if ResMed has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 161.91 | 162.57 | |
| Return On Tangible Assets | 0.30 | 0.32 | |
| Return On Capital Employed | 0.24 | 0.14 | |
| Return On Assets | 0.17 | 0.10 | |
| Return On Equity | 0.23 | 0.14 |
Things to note about ResMed Inc performance evaluation
Checking the ongoing alerts about ResMed for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ResMed Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| ResMed Inc generated a negative expected return over the last 90 days | |
| ResMed Inc has a strong financial position based on the latest SEC filings | |
| About 65.0% of the company shares are owned by institutional investors | |
| On 18th of September 2025 ResMed paid $ 0.6 per share dividend to its current shareholders | |
| Latest headline from fool.com.au: How to make your first 10,000 in the ASX share market |
- Analyzing ResMed's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ResMed's stock is overvalued or undervalued compared to its peers.
- Examining ResMed's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ResMed's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ResMed's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ResMed's stock. These opinions can provide insight into ResMed's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for ResMed Stock analysis
When running ResMed's price analysis, check to measure ResMed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ResMed is operating at the current time. Most of ResMed's value examination focuses on studying past and present price action to predict the probability of ResMed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ResMed's price. Additionally, you may evaluate how the addition of ResMed to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |